MICHELLE ALBERTY: Open Payments
NPI 1205653615 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 43 payments from 26 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $97 |
| Novo Nordisk Inc | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| ABBVIE INC. | 3 | $52 |
| Corcept Therapeutics | 2 | $48 |
| Abbott Laboratories | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Dynavax Technologies Corporation | 2 | $34 |
| Exact Sciences Corporation | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: Kerendia, MOUNJARO, Korlym, FREESTYLE LIBRE 3, Wegovy, VRAYLAR, Heplisav-B, Ozempic.
Industry payments across TX — which companies pay providers there.
